Neurocrine Financial Overview
Neurocrine's market cap is currently $14.46B. The company's EPS TTM is $2.04; its P/E ratio is 34.63; Neurocrine is scheduled to report earnings on October 28, 2025, and the estimated EPS forecast is $1.86. See an overview of income statement, balance sheet, and cash flow financials.
